Skip to main content

Advertisement

SpringerLink
Log in

Role of artificial liver support in hepatic encephalopathy

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Hepatic encephalopathy (HE) refers to the reversible neuropsychiatric disorders observed in acute liver failure and as a complication of cirrhosis and/or portal hypertension. This review aims to describe the pathophysiology of HE, the rationale for the use of artificial liver support in the treatment of HE, the different concepts of artificial liver support and the results obtained. Ammonia has been considered central to its pathogenesis but recently an important role for its interaction with inflammatory responses and auto-regulation of cerebral hemodynamics has been suggested. Artificial liver support might be able to decrease ammonia and modulate inflammatory mediators and cerebral hemodynamics. Bioartificial liver support systems use hepatocytes in an extracorporeal device connected to the patient’s circulation. Artificial liver support is intended to remove protein-bound toxins and water-soluble toxins without providing synthetic function. Both systems improve clinical and biochemical parameters and can be applied safely to patients. Clinical studies have shown that artificial liver support, especially albumin dialysis, is able to improve HE in acute and acute-on-chronic liver failure. Further studies are required to better understand the mechanism, however, artificial liver support can be added to the therapeutic bundle in treating HE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Aggarwal S et al (2005) Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Liver Transpl 11:1353–1360

    Article  PubMed  Google Scholar 

  • Ash SR et al (2000) Push-pull sorbent-based pheresis and hemodiabsorption in the treatment of hepatic failure: preliminary results of a clinical trial with the BioLogic-DTPF System. Ther Apher 4:218–228

    Article  PubMed  CAS  Google Scholar 

  • Bernal W et al (2007) Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46:1844–1852

    Article  PubMed  CAS  Google Scholar 

  • Bhatia V et al (2006) Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55:98–104

    Article  PubMed  CAS  Google Scholar 

  • Bustamante J et al (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895

    Article  PubMed  CAS  Google Scholar 

  • Cauli O, Rodrigo R, Piedrafita B, Boix JB, Felipo V (2007) inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with chronic liver failure. Hepatology 46(2):514–519

    Article  PubMed  CAS  Google Scholar 

  • Clemmesen JO et al (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29:648–53

    Article  PubMed  CAS  Google Scholar 

  • Cordoba J et al (1996) Determinants of ammonia clearance by hemodialysis. Artif Organs 20:800–803

    Article  PubMed  CAS  Google Scholar 

  • Davies NA et al (2005) Serum albumin shows conformational, structural and functional abnormalities in cirrhotic patients, which worsens with severity of liver disease and are unaffescted by albumin dialysis. Hepatology 42:A66

    Google Scholar 

  • Desjardins P et al (1999) Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle. Metab Brain Dis 14:273–280

    Article  PubMed  CAS  Google Scholar 

  • Eiseman B (1966) Treatment of hepatic coma by extracorporeal liver perfusion. Ann R Coll Surg Engl 38:329–348

    PubMed  CAS  Google Scholar 

  • Ellis AJ et al (1999) Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the biologic-DT. Int J Artif Organs 22:27–34

    PubMed  Google Scholar 

  • Falkenhagen D et al (1999) Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 23:81–86

    Article  PubMed  CAS  Google Scholar 

  • Ferenci P et al (2002) Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721

    Article  PubMed  Google Scholar 

  • Gabduzda GJ, Hall PW 3rd (1966) Relation of potassium depletion to renal ammonium metabolism and hepatic coma. Medicine (Baltimore) 45:481–490

    Article  CAS  Google Scholar 

  • Hassanein TI et al (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46:1853–1862

    Article  PubMed  CAS  Google Scholar 

  • Haussinger D et al (2000) Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32:1035–1038

    Article  PubMed  CAS  Google Scholar 

  • Heemann U et al (2002) Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 36:949–958

    PubMed  CAS  Google Scholar 

  • Hiroma T et al (2002) Continuous venovenous hemodiafiltration in neonatal onset hyperammonemia. Am J Perinatol 19:221–224

    Article  PubMed  Google Scholar 

  • Hughes RD (2002) Review of methods to remove protein-bound substances in liver failure. Int J Artif Organs 25:911–917

    PubMed  CAS  Google Scholar 

  • Hughes RD et al (1994) Evaluation of the biologic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure. Int J Artif Organs 17:657–662

    PubMed  CAS  Google Scholar 

  • Jalan R, Kapoor D (2004) Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci (Lond) 106:467–474

    Article  CAS  Google Scholar 

  • Jalan R et al (1997) Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 27:928–933

    Article  PubMed  CAS  Google Scholar 

  • Jalan R et al (2002) Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol 37:536–538

    Article  PubMed  CAS  Google Scholar 

  • Jalan R et al (2004) Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41:613–620

    Article  PubMed  CAS  Google Scholar 

  • Jover R et al (2006) Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology 43:1257–1266

    Article  PubMed  CAS  Google Scholar 

  • Jurgens G et al (2002) Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A. J Endotoxin Res 8:115–126

    PubMed  CAS  Google Scholar 

  • Kiley JE et al (1956) Removal of blood ammonia by hemodialysis. Proc Soc Exp Biol Med 91:489–490

    PubMed  CAS  Google Scholar 

  • Krisper P et al (2005) In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 43:451–457

    Article  PubMed  CAS  Google Scholar 

  • Laleman W et al (2006) Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10:R108

    Article  PubMed  Google Scholar 

  • Lepore MJ, Martel AJ (1970) Plasmapheresis with plasma exchange in hepatic coma. Methods and results in five patients with acute fulminant hepatic necrosis. Ann Intern Med 72:165–174

    CAS  Google Scholar 

  • Lockwood AH et al (1979) The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 63:449–460

    CAS  Google Scholar 

  • Master S et al (1999) Cerebral blood flow and the development of ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 30:876–880

    Article  PubMed  CAS  Google Scholar 

  • Mitzner SR et al (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277–286

    Article  PubMed  CAS  Google Scholar 

  • Mitzner SR et al (2001) Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 5:417–422

    Article  PubMed  CAS  Google Scholar 

  • Mitzner S et al (2002) Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS—a review of clinical, biochemical, and electrophysiological data. Metab Brain Dis 17:463–475

    Article  PubMed  CAS  Google Scholar 

  • Mookerjee R et al. (2007) Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology.Aug 6 [epub ahead of print]

  • Muto Y et al (1988) Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2:72–74

    Article  PubMed  CAS  Google Scholar 

  • Oettl K et al. (2006). Redox state of serum albumin and carbonyl content of plasma proteins in advanced liver disease. Proceedings of the 13th Biennal Congress of the Society for Free Radical Research International:265–268

  • O’Grady JG (2005) Acute liver failure. Postgrad Med J 81:148–154

    Article  PubMed  CAS  Google Scholar 

  • O’Grady JG et al (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439–445

    PubMed  CAS  Google Scholar 

  • Olde Damink SW et al (2003) The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology 37:1277–1285

    Article  PubMed  Google Scholar 

  • Opolon P et al (1976) Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD). Trans Am Soc Artif Intern Organs 22:701–710

    PubMed  CAS  Google Scholar 

  • Ortega R et al (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36:941–948

    PubMed  CAS  Google Scholar 

  • Pedersen HR et al (2007) Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital. J Hepatol 47:245–252

    Article  PubMed  CAS  Google Scholar 

  • Peszynski P et al (2002) Albumin dialysis: single pass vs. recirculation (MARS). Liver 22(Suppl 2):40–42

    Article  PubMed  CAS  Google Scholar 

  • Prass K et al (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198:725–736

    Article  PubMed  CAS  Google Scholar 

  • Quinlan GJ et al (2005) Albumin: biochemical properties and therapeutic potential. Hepatology 41:1211–1219

    Article  PubMed  CAS  Google Scholar 

  • Rifai K et al (2003) Prometheus—a new extracorporeal system for the treatment of liver failure. J Hepatol 39:984–990

    Article  PubMed  CAS  Google Scholar 

  • Rifai K et al (2006) Removal selectivity of Prometheus: a new extracorporeal liver support device. World J Gastroenterol 12:940–944

    PubMed  Google Scholar 

  • Rolando N et al (1990) Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 11:49–53

    Article  PubMed  CAS  Google Scholar 

  • Rolando N et al (2000) The systemic inflammatory response syndrome in acute liver failure. Hepatology 32:734–739

    Article  PubMed  CAS  Google Scholar 

  • Romero-Gomez M et al (2004a) Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol 41:49–54

    Article  PubMed  CAS  Google Scholar 

  • Romero-Gomez M et al (2004b) Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology 39:939–943

    Article  PubMed  Google Scholar 

  • Rose CL, Ytrebø LM, Davies NA, Sen S, Nedredal GI, Belanger M, Williams R, Revhaug A, Jalan R (2007) Reduction of extracellular ammonia and lactate is associated with attenuation of intracranial hypertension in acute liver failure pigs. Hepatology 46(6):1883–1892

    Article  PubMed  CAS  Google Scholar 

  • Rozga J (2006) Liver support technology—an update. Xenotransplantation 13:380–389

    Article  PubMed  Google Scholar 

  • Sabin S, Merritt JA (1968) Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange). Ann Intern Med 68:1–7

    PubMed  CAS  Google Scholar 

  • Sauer IM et al (2004) In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 39:1408–1414

    Article  PubMed  CAS  Google Scholar 

  • Schmidt LE et al (2001a) Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl 7:709–712

    Article  PubMed  CAS  Google Scholar 

  • Schmidt LE et al (2001b) Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 7:1034–1039

    Article  PubMed  CAS  Google Scholar 

  • Schmidt LE et al (2003) Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 9:290–297

    Article  PubMed  Google Scholar 

  • Sen S et al (2004a) Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs. Intensive Care Med 30:496–501

    Article  PubMed  Google Scholar 

  • Sen S et al (2004b) Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 10:1109–1119

    Article  PubMed  Google Scholar 

  • Sen S et al (2006) Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med 34:158–164

    Article  PubMed  Google Scholar 

  • Shawcross DL et al (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40:247–254

    Article  PubMed  CAS  Google Scholar 

  • Shawcross DL et al (2007a) Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 22:125–138

    Article  PubMed  CAS  Google Scholar 

  • Shawcross D et al (2007b) Ammonia and hyponatremia impairs neutrophil function by inducing swelling and is modulated by the p38_MAPK pathway. Gastroenterology 46:A841

    Google Scholar 

  • Sorkine P et al (2001) Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 29:1332–1336

    Article  PubMed  CAS  Google Scholar 

  • Sort P et al (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409

    Article  PubMed  CAS  Google Scholar 

  • Stadlbauer V et al (2006) Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 10:R169

    Article  PubMed  Google Scholar 

  • Stadlbauer V et al (2008) Artificial liver support systems in the management of complications of cirrhosis. Semin Liver Dis 28:96–109

    Article  PubMed  CAS  Google Scholar 

  • Stange J, Mitzner S (1996) A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 19:677–691

    CAS  Google Scholar 

  • Stange J et al (1993) Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 17:809–813

    PubMed  CAS  Google Scholar 

  • Stange J et al (1999) Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23:319–330

    Article  PubMed  CAS  Google Scholar 

  • Stewart CA et al (2007) Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13:1366–1371

    Article  PubMed  Google Scholar 

  • Thalheimer U et al (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54:556–563

    Article  PubMed  CAS  Google Scholar 

  • Vaquero J et al (2003) Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125:755–764

    Article  PubMed  Google Scholar 

  • Wright G, Jalan R (2007) Management of hepatic encephalopathy in patients with cirrhosis. Best Pract Res Clin Gastroenterol 21:95–110

    Article  PubMed  Google Scholar 

  • Wright G et al (2007) Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 45(6):1517–1526

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Hepatology, University College London Medical School, 69-75 Chenies Mews, London, WC1E 6HX, UK

    V. Stadlbauer, G. A. K. Wright & R. Jalan

  2. Department of Internal Medicine, Medical University of Graz, Graz, Austria

    V. Stadlbauer

Authors
  1. V. Stadlbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. A. K. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Jalan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Jalan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stadlbauer, V., Wright, G.A.K. & Jalan, R. Role of artificial liver support in hepatic encephalopathy. Metab Brain Dis 24, 15–26 (2009). https://doi.org/10.1007/s11011-008-9117-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-008-9117-2

Keywords

Search

Navigation